Interventional Pulmonology Program
The National Jewish Health Interventional Pulmonology Program in Denver, Colorado, offers a wide range of minimally invasive diagnostic, therapeutic and palliative (symptom-relieving) airway procedures. Our interventional pulmonologists are fellowship-trained and have extensive experience performing minimally invasive procedures that help accurately diagnose patients with lung nodules and other lung concerns.
In partnership with Saint Joseph Hospital, National Jewish Health is among the first hospitals in the Rocky Mountain region to offer robotic bronchoscopy as minimally invasive option for patients with lung nodules and other lung concerns that need to be biopsied.
Learn more about Robotic Bronchoscopy Program
Our Services
- Identify, diagnose and treat pulmonary nodules
- Early detection of lung cancer
- Diagnose and treat airway obstructions due to benign and malignant diseases
- Airway recanalization with laser and other modalities
- Removal of foreign bodies
- Pleural disease management
- Management of advanced asthma and emphysema
Interventional Pulmonology Procedures
- Flexible bronchoscopy
- Endobronchial Ultrasound System (EBUS)
- Robotic bronchoscopy
- Rigid bronchoscopy
- Laser Bronchoscopy
- Electrocautery
- Argon Plasma Coagulation
- Balloon dilation
- Airway stent placement
- Endobronchial valve placement
- Bronchial thermoplasty
- Thoracentesis
- Chest tube placement
- Indwelling tunneled pleural catheter placement
Doctors
-
Kristen Glisinski, MD
-
Ellen Volker, MD, MSPH
Clinical Trials
Idiopathic Pulmonary Fibrosis (IPF) & GERD
The purpose of this study is to measure and accurately identify the presence and severity of gastroesphageal reflux disease (GERD), commonly called acid reflux, in idiopathic pulmonary fibrosis (IPF) patients using the Supraglottic Index (SGI).
Learn More- ADRN-12/LEADS (Longitudinal Endotyping of Atopic Dermatitis Through Transcriptomic Skin Analysis)
- Atopic Dermatitis & Skin Infections
- BBT-877: Possible Treatment for Idiopathic Pulmonary Fibrosis
- BEACON-CF: Investigational mRNA Therapy for Cystic Fibrosis
- Biomarkers & Hypersensitivity Pneumonitis Progression
- Blood Test to Help Identify Cancer
- Can Pembrolizumab (MK3475) with SBRT Treatment Stop or Slow Non-Small Cell Lung Cancer?
- CHARM Study for Asthma
- Creating Asthma Measurements through the MORRE Study
- Effects of Pregnancy for Cystic Fibrosis Patients
- Extensive Stage Small Cell Lung Cancer Combination Treatment
- Healthy Adults Needed for Beryllium Disease Study
- Healthy People Needed for Sarcoidosis Research
- Identifying Characteristics and Patterns of Asthma
- ILD & Early Rheumatoid Arthritis
- Immune Pathways & Development of Sarcoidosis
- Improving Treatment for IPF
- Investigational Gene Therapy for Adults with CF
- Link Between Rheumatoid Arthritis & Lung Disease
- Lung Cancer & COVID Infection
- Lung Injury from Military Deployment
- Mineral Dust & Lung Disease
- MyAI Registry for People with Adrenal Insufficiency
- New Trial Medication for Pulmonary Arterial Hypertension
- NICE-CF: Colon Cancer Screening for adults with Cystic Fibrosis
- OCEAN Study for EGPA
- Potential New Treatment for Metastatic Lung Cancer
- Potential New Treatment for Metastatic Lung Cancer
- PRA023 for Systemic Sclerosis with Interstitial Lung Disease
- Predict and Prevent Lung Disease
- Predicting ILD from Hypersensitivity Pneumonitis
- Pulmonary Arterial Hypertension & increased dose of Opsumit
- Pulmonary Fibrosis & Genetic Factors
- RESOLVE-Lung Study for Pulmonary Sarcoidosis
- Silicosis Registry
- Skin Reactions to Cancer Immunotherapy
- Skin, Airway & Esophageal Epithelial Barriers in Youth
- SUNBEAM: Studying Allergy Development in Babies
- SUNRISE Trial for Oral Steroid Dependent Asthma
- Treating Deployment-Related Asthma with Supplements
- Understanding Allergy Development in Infants
- Understanding Reproductive Health Concerns in Men with CF
- Understanding Skin Problems from Eczema and Food Allergies
- XTMAB-16: A New Drug to Reduce Steroid Use in Sarcoidosis
Reasons to Choose National Jewish Health
- The leading respiratory hospital in the nation and the only one devoted fully to the treatment of respiratory and related illnesses
- Ranked #1 or #2 in Pulmonology by U.S. News & World Report for 26 consecutive years
- Ranked in the top 5% of hospitals in the nation by HCAHPS
- Physicians consistently recognized among the best in the nation by multiple services, including Best Doctors in America and Castle Connolly
- Among the top 6% of organizations funded for research by the NIH, providing patients access to hundreds of active clinical trials
- 124-year history of focus on care, research and education serving patients from around the world with lung, heart, immune and related disorders
Former Asthma Patient Runs 100th Half-Marathon for National Jewish Health
“I wanted to say thank you for what National Jewish Health did for my family and me so many years ago,” Buron said. “Achieving this milestone would not have been possible without the incredible care I received as a child.”
Read More